Immunization Status and Risk of Measles/Rubella Incidence During Outbreak

Yurnila Yurnila, Evi Martha

Abstract


Background: In 2018, measles remained a leading cause of morbidity and mortality worldwide, with over 9.7 million cases and more than 140,000 deaths associated with this disease. Additionally, rubella also has long-term health consequences, with an estimated 103,000 infants born with Congenital Rubella Syndrome (CRS). In 2022, there was a significant increase in the number of laboratory-confirmed measles cases, totaling 4,845 cases, with six resulting in death (CFR 0.1%). Some of the provinces most affected were Aceh, West Sumatra, and East Java. In 2022, the city of Pariaman was declared a state of emergency (KLB) for measles.

Aims: To analyze the link between immunization status and measles/rubella incidents during the KLB event in Pariaman City in 2022.

Method: Quantitative research with a case-control design. In this study, the researchers used secondary data contained in the annual report of Pariaman City Health Service for 2022. The researchers employed a parametric test with Chi-Square statistical test using the IBM SPSS computer program to determine the interaction between the two variables.

Results: The results of the study showed that there was a relationship between a history of immunization and the occurrence of measles/rubella in Pariaman City. P = 0.032 (p < 0.05). An OR value of 3.25 (95% CI = 1.209 – 8.733) indicated that a history of non-immunization had a 3.25 times greater risk of exposure to measles/rubella than a history of immunization.

Conclusion: Immunization history affects the outbreak in Pariaman City in 2022.

Full Text:

PDF

References


World Health Organization., “Measles fact sheet.” doi: (https://www.who.int/news-room/ fact-sheets/detail/measles.

World Health Organization, “Measles - Indonesia,” 2023. Accessed: Aug. 21, 2023. [Online]. Available: https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON462

Badan Pusat Statistik, “Persentase Balita yang Pernah Mendapat Imunisasi Campak (Persen), 2020-2022.” [Online]. Available: https://www.bps.go.id/indicator/30/211/1/persentase-balita-yang-pernah-mendapat-imunisasi-campak.html

Dinas Kesehatan Provinsi Sumatra Barat Tahun 2022, “Profil Kesehatan Sumatra Barat,” Padang, 2023.

Dinas Kesehatan Kota Pariaman, “Profil Kesehatan Kota Pariaman Tahun 2022,” Pariaman, 2023.

K. K. RI, Petunjuk Teknis Kampanye Imunisasi Meales Rubella (MR). Jakarta, 2017.

S. Notoatmodjo, Promosi Kesehatan dan Perilaku Kesehatan. Rineka Cipta, 2014.

A. Nasika et al., “Measles Immunity Status og Greek Population After the Outbreak in 2017 - 2018 : Result From a Seroprevalence National Survey,” MDPI, vol. 11, no. 1220, 2023.

A. Jama, M. Ali, A. Lindstrand, R. Butler, and A. Kulane, “Perspectives on the Measles, Mumps and Rubella Vaccination among Somali Mothers in Stckholm,” Int. J. Enviromental Res. ang Public Heal., vol. 15, 2018.

A. F. Lubanga et al., “Malawi vaccination drive: An integrated immunization campaign against typoid, measles, rubella, and polio; health benefits and potential chalenges,” Hum. Vaccin. Immunother., vol. 19, no. No 2, 2233397, 2023, [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337493/

Laras Arsyi Insani and I. D. Prakoso, “Hubungan Antara Pemberian Imunisasi Campak dengan Kejadian Campak di Provinsi Daerah Khusus Ibukota Jakarta,” Media Gizi Kesmas Univ. Airlangga, vol. 11, pp. 130–136, 2022.

S. Notoatmodjo, Metodologi Penelitian Kesehatan. Rineka Cipta, 2018.

K. E. Oktaviasari, “Hubungan Imunisasi Campak dengan kejadian Campak di Provinsi Jawa Timur,” J. Berk. Epidemiol., vol. 6, no. 2, pp. 166–173, 2018.

Kementrian Kesehatan RI, Peraturan Menteri Kesehatan Republik Indonesia Nomor 12 Tentang Penyelenggaraan Imunisasi. Jakarta, 2017.

N. A. Juniarti, Firdaus J Kunoli, “Faktor Resiko Kejadian Campak di Dusun Wandu Desa Salubomba ilayah Kerja Puskesmas Donggala,” Promotif, vol. 6, no. 1, pp. 45–54, 2016.

D. K. K. Pariaman, Panduan Keagamaan Dalam Penyelanggaraan Imunisasi Measles dan Rubella (MR). Pariaman: Dinas Kesehatan Kota Pariaman, 2019.

E. Uki, N. heny Purwati, and T. Sulastri, “Analisis Faktor yang Berhubungan dengan Pemberian Imunisasi Measles Rubella Pada Anak Balita,” J. Ilm. Kesehat. Pers., vol. 09 (2), pp. 72–80, 2020.

Elsa Matchica Naibaho and Ernawati, “Hubungan Faktor - Faktor yang Mempengaruhi Kelengkapan Imunisasi Dengan Kepatuhan Imunisasi MR (Measles Rubella) Lanjutan di Wilayah Kerja Puskesmas Air Rami Kabupaten Muko - Muko Bengkulu,” Tarumanagara Med. J., vol. 3, no. 2, pp. 304–311, 2021, [Online]. Available: https://journal.untar.ac.id/index.php/tmj/article/view/13721

B. Nuzaini and D. Sayati, “Faktor - Faktor yang Berhubungan Terhadap Pelaksanaan Imunisasi Meales Rubella di Wilayah Kerja Puskesmas Tegal Binangun Palembang Tahun 2019,” J. Bina Husada, vol. 13, no. No 1, pp. 19–28, 2021, [Online]. Available: https://karya.brin.go.id/id/eprint/17856/1/Jurnal_Bella Nuzaini_STIK Bina Husada Palembang_2021.pdf

S. L. Rosas et al., “Improving Immunization Rates During the 2019 Measles Outbreak,” Heal. J. Prim. care Community, vol. 13: 1–5, 2022, [Online]. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841912/

C.Prosperi et al., “Added value of the measles-rubella supplementary immunizatio activity in reaching unvaccinated and under - vaccinated children, a cross-sectional study in five indian districts, 2018 - 2020,” www.elsevier.com/locate/vaccine, vol. 41, pp. 486–495, 2023, [Online]. Available: https://pubmed.ncbi.nlm.nih.gov/36481106/

H. Sarma et al., “Implementation of the World’s largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation,” BMC Public Health, vol. 19:925, 2019, [Online]. Available: https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-019-7176-4

S. S. Datta et al., “Progress and challenges in measles and rubella elimination in the WHO European Region,” HHS Public Access, 2019.




DOI: https://doi.org/10.35730/jk.v15i1.1055

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.